Daniele Tognetti

Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients

M. Antonelli, J. Caballero, J. Riera, 2023, Intensive Care Medicine.

Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

J. Caballero, J. Riera, D. García-Gasulla, 2022, Intensive Care Medicine.

The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

J. Caballero, J. Riera, F. Rodríguez de Castro, 2021, Critical Care.